T1	Participants 1405 1517	Naltrexone was associated with modest improvement of behavior in 11 of 24 children, but learning did not improve
T2	Participants 867 1005	Comparisons between naltrexone and baseline, but not naltrexone and placebo, on parent and teacher ratings showed statistical significance
T3	Participants 245 405	Eleven children with autistic disorder, aged 3.0 to 8.3 years, were studied in home, school, and outpatient laboratory, bringing to 24 the combined study sample
T4	Participants 91 236	This study expanded upon previous work on naltrexone efficacy and safety in young autistic children and assessed performance on learning measures
